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Effector-T-cell-mediated immunity depends on the
efficient localization of antigen-primed lymphocytes
to antigen-rich non-lymphoid tissue, which is facili-
tated by the expression of a unique set of ‘‘homing’’
receptors acquired by memory T cells. We report
that engagement of the hepatocyte growth factor
(HGF) receptor c-Met by heart-produced HGF during
priming in the lymph nodes instructs T cell cardio-
tropism, which was associated with a specialized
homing ‘‘signature’’ (c-Met+CCR4+CXCR3+). c-Met
signals facilitated T cell recruitment to the heart via
the chemokine receptor CCR5 by inducing autocrine
CCR5 ligand release. c-Met triggering was sufficient
to support cardiotropic T cell recirculation, while
CCR4 andCXCR3 sustained recruitment during heart
inflammation. Transient pharmacological blockade
of c-Met during T cell priming led to enhanced sur-
vival of heart, but not skin, allografts associated
with impaired localization of alloreactive T cells to
heart grafts. These findings suggest c-Met as a target
for development of organ-selective immunosuppres-
sive therapies.
INTRODUCTION
The migratory patterns of naive and memory T lymphocytes are
well defined and vary depending on their activation, differentia-
tion, and function. Through expression of a unique set of adhe-
sion molecules and chemokine receptors, so-called ‘‘homing’’
receptors, distinct memory T cell populations are able to interact
with organ-specific endothelial cells (ECs) and are recruited to
distinct target tissues. For example, lymphocyte trafficking to
the intestinal lamina propria is mediated by the interaction be-tween intestinal mucosal addressin cell adhesionmolecule-1 ex-
pressed by gut endothelium, and lymphocyte a4b7 integrin. T cell
migration to the skin is promoted by cutaneous lymphocyte-
associated antigen (CLA) interaction with vascular E-selectin
with the involvement of chemokine-receptor pairs CCR4-
CCL17, CCR10-CCL27, and CCR8-CCL1 (McCully et al., 2012;
Mora and von Andrian, 2006).
During antigen activation of naive T cells, the microenviron-
ment of the draining lymphoid tissue provides vital cues for the
acquisition of peripheral homing preference. For example,
dendritic cells (DCs) derived from gut-associated lymphoid tis-
sue (GALT) have been shown to instruct gut tropism, via the pro-
duction of retinoic acid from vitamin A (Mora and von Andrian,
2006). Similarly, skin DCs produce the vitamin D3 metabolite
1,25(OH)2D3, which favors the induction of skin-homing lympho-
cytes (Mora and von Andrian, 2006). With the exception of gut
and skin, the molecular signature and imprinting mechanisms
that define preferential homing to other organs are largely
elusive. Most studies have focused on the role of adhesion and
chemokine receptors, but the extensive overlap in the expres-
sion of these molecules by lymphocytes retrieved from different
tissues has prevented the identification of tissue-selective area
codes.
It has been recently proposed that soluble factors produced
by the tissue itself might contribute to T cell homing imprinting.
For example, skin-derived soluble factors have been shown to
induce the skin homing receptor CCR8 in T cells (McCully
et al., 2012). It is known that tissue-derived small molecules
can be directly delivered to draining lymph nodes by anatomi-
cally defined conduits (Gretz et al., 2000). Some of these mole-
cules are produced in a tissue-specificmanner and can therefore
define the topographic identity of the tissue where they are
generated in the draining lymphoid tissue and possibly
contribute to T cell homing imprinting (Campbell et al., 2003).
HGF is a pleiotropic cytokine that plays important functions in
organ development, regeneration, and cancer by activating its
tyrosine kinase receptor c-Met (Zhang and Vande Woude,
2003). A key feature of HGF is its ability to promote cell migrationImmunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1087
(Zhang and Vande Woude, 2003). In immune processes, HGF
can induce chemotactic responses by liver-derived human T
lymphocytes (Adams et al., 1994) and maintains the differentia-
tion of human hepatic sinusoidal endothelial cells, which
specialize in lymphocyte recruitment to the liver (Lalor et al.,
2006). TheHGF-c-Met axis has also been implicated in themobi-
lization of cardiac progenitor cells (Leri et al., 2005). Based on
these reports, we have investigated the effects of T cell exposure
to HGF during activation on their migration and homing patterns.
Our findings reveal that engagement of HGF-c-Met axis during
priming induces ‘‘heart-homing’’ signature T cells and also indi-
rectly mediates their recirculation in cardiac tissue.
RESULTS
Engagement of the HGF-c-Met Axis during Activation
Induces Distinctive Migratory Features in T Cells
To investigate the effects of HGF on T cell migration, we first as-
sessed the expression of the HGF receptor c-Met and the effects
of its stimulation on T cell functions. Naive T (Tn) cells were found
to express low amounts of c-Met (Figure 1A) and displayed
modest but reproducible migratory responses to HGF (Fig-
ure 1B), which were prevented by pre-treatment with the
c-Met-specific inhibitor PHA-665752 (Rodig and Shapiro,
2010) or by selective inhibition of c-Met in T cells with lentivi-
ral-delivered, specific shRNAs (Figures S1A–S1C), which
confirmed the specificity of the c-Met small molecule inhibitor.
In contrast, c-Met inhibition did not affect T cell migration
induced by the chemokines CCL19 and CCL21 (Figure 1C),
which stimulate naive T cell migration via CCR7 (Okada et al.,
1998). Naive T cells were subsequently activated for 7 days by
plastic-bound anti-CD3 and anti-CD28 antibodies either in the
presence (Thgf) or absence (Tnt) of HGF, which was added at
a concentration of 15 ng/ml, a dose determined by preliminary
experiments of HGF-induced chemokinesis by naive T cells.
Exposure to HGF during activation did not affect T cell division
or cytokine production (Figures S1F–S1I). In contrast, only Thgf
cells upregulated c-Met (Figures 1D, 1E, and S1J–S1L) and
maintained the ability to migrate to this cytokine, which was pre-
vented by the c-Met inhibitor (Figures 1F and 1G). The inhibitor
did not affect either spontaneous migration of Thgf or Tnt cells
or migration of Thgf cells in response to the chemokine CCL5
(Figures 1G–1I), which induces migration of activated T cells
(Okada et al., 1998). In addition, we observed that the presence
of HGF increased adhesion of Thgf cells to VCAM-1 in a flow sys-
tem (Figures S1M and S1N), suggesting that c-Met signaling
might enhance integrin-mediated adhesion, as previously re-
ported (Zhang and VandeWoude, 2003). c-Met-mediatedmigra-
tory responses to HGF were mediated by an Akt-dependent
pathway, which was not activated in c-Met-negative Tnt cells
(Figures S2A–S2F). In addition, HGF-induced chemokinesis
required signal transducer and activator of transcription 3
(STAT3) activity (Figures S2G and S2H), which has been reported
to be dispensable for chemokine receptor signaling (Khabbazi
et al., 2013).
We further investigated the migratory signature induced in
T cells byHGF by comparing the phenotype of Thgf and Tnt cells.
Expression of a number of surface molecules (Figure S2I) and
migratory characteristics also revealed that, compared to Tnt1088 Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authorscells, Thgf cells expressed higher amounts of the chemokine
receptor CXCR3 (Figures 1J and 1K), which correlated with
enhanced chemotactic responses to CXCL10 and increased
responsiveness to CCL22, this occurring with various degrees
of upregulation of its receptor CCR4 (Figures 1L–1O).
Overall, these data indicate that signals induced by the
HGF-c-Met axis during T cell activation favor the emergence of
a T cell population with distinctive migratory features, including
c-Met expression and the ability to migrate in response to HGF
via an Akt- and STAT3-dependent pathway.
c-Met Promotes T Cell Migration by Inducing Autocrine
Chemokine Release
Although HGF has been defined as a chemoattractant by a num-
ber of studies (Zhang and Vande Woude, 2003), its cognate re-
ceptor c-Met does not belong to the G protein-coupled receptor
family, the canonical trans-membrane proteins that transduce
chemotactic activity. Many of them effect of c-Met signaling,
including activation of integrins and intracellular mediators
of cytoskeleton rearrangements (Zhang and Vande Woude,
2003), and our own observations that HGF induces chemokine-
sis and T cell adhesion (Figures 1, S1M, and S1N) closely
resemble those of chemokine receptors. We therefore investi-
gated in more depth the mechanism of HGF-induced chemoki-
nesis. First, the effect of Thgf cell pretreatment with the
GPCR-G1 inhibitor pertussis toxin (PTX) on HGF-induced che-
mokinesis was investigated in vitro and in vivo. As shown in Fig-
ure 2A, PTX treatment abrogated Thgf cell migration elicited by
HGF in transwell. In vivo, migration of adoptively transferred
(i.v.) Thgf cells to the peritoneal cavity of mice, which received
HGF (100 ng/mouse) i.p. 30 min earlier, was inhibited by T cell
pretreatment with PTX (Figures 2B and 2C). These observations
suggest that GPCR-Gai signals are mediating HGF-induced
chemokinesis, implying a crosstalk between c-Met and these
receptors.
Although c-Met has been described to be physically associ-
ated to—and potentiate signaling of—other membrane recep-
tors, including integrins (Trusolino et al., 2001), the possibility
that c-Met might increase GPCR signaling is unlikely based on
the observation that Thgf cells do not display enhanced re-
sponses to CCL5 (as previously shown in Figure 1I). In addition,
HGF stimulation of a variety of cells has been shown to induce
chemokine production and secretion (Kaibori et al., 2006; Mat-
suda-Hashii et al., 2004; Tu et al., 2009). We therefore investi-
gated the alternative possibility that c-Met triggering might
indirectly induce chemokinesis by stimulating the release of
GPCR ligands by the T cell itself. Migration of Tnt cells—which
do not migrate in response to HGF—to supernatants (SNs)
from Thgf cells unstimulated or re-exposed to HGF overnight
was measured in a transwell assay. As shown in Figure 2D, Tnt
cells migrated in response to SNs from Thgf cells stimulated
with HGF but not those kept in medium alone. As expected,
HGF alone did not induce chemokinesis of Tnt cells, thus ruling
out the possibility of chemokinesis induced by HGF contained
in the SNs. These data suggest that c-Met might increase che-
mokinesis of Thgf cells by inducing the release of GPCR ligands.
T lymphocytes have been reported to secrete members of the
b-chemokine family, particularly CCL4, which in turn can affect
T cells in an autocrine loop (Casazza et al., 2009; Tanaka et al.,
Figure 1. T Cell Activation in the Presence of HGF Induces a Distinct Migratory Phenotype
(A–C) Naive T (Tn) cells were isolated from lymph nodes of C57BL/6 mice. In (A), expression of the HGF receptor c-Met is shown. Naive T cell (106 cells/well)
migration in response to HGF (15 ng/ml) (B) or to CCL19/21 (200 ng/ml) (C) was measured by transwell assay at the indicated time points. In some instances,
T cells were treated with the c-Met inhibitor (INH) PHA-665752 (0.3 ng/ml) overnight at 37C prior to the migration assay.
(D–I) Naive T cells were subsequently activated by plastic-bound anti-CD3 and anti-CD28 antibodies in the presence of HGF (Thgf) or inmedium alone (Tnt). c-Met
expression by Thgf and Tnt 24 hr after stimulation is shown in (D), and the mean differential MFI (MFIcMet  MFIIsC) in three experiments of identical design
is shown in (E). T cells were harvested after a week of culture and their migratory responses to HGF (F) measured by transwell assays. Some T cells were
pretreated with the c-Met inhibitor (INH) PHA-665752 (0.3 ng/ml) overnight at 37C (G and H). Chemokinesis of Thgf and Tnt cells in response to CCL5 (100 ng/ml)
is shown in (I).
(J–O) Expression of CXCR3 (J and K) and CCR4 (M and N) and response to their chemokine ligands CXCL10 and CCL22 by naive T, Thgf, and Tnt cells; (A) and (D)
show representative histograms. Chemokinesis to CXCL10 and CCL22 (at 4 hr), is shown in (L) and (O), respectively. Data are represented as the differential mean
fluorescence intensity from isotype control (DMFI) (K andN) ormean percentage T cell migration (L andO)measured in three independent experiments of identical
design (±SD).1998). We therefore investigated the production of CCL4 by Thgf
cells either stimulated with HGF overnight or unstimulated, and
we observed an increase in intracellular CCL4 contained in large
vesicles in Thgf cells after stimulation with HGF (Figures 2E–2G).
Antibody neutralization of CCL4 significantly inhibited migrationof Tnt cells in response to SNs obtained from Thgf cells re-stim-
ulated with HGF (Figure 2H). Further, CCL4 neutralization in-
hibited Thgf cell adhesion to VCAM-1 in a flow chamber system
(Figure 2I), suggesting that c-Met signals not only promote CCL4
production, but also induce its release from the T cell. This,Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1089
Figure 2. Mechanisms of c-Met-Induced Migration
(A–C) Thgf cell migration in response to HGF (15 ng/ml) (B) or to CXCL10 (200 ng/ml) (C) was measured by transwell assays in vitro (A) and by assessing their
migration to i.p.-administered HGF (100 ng/mouse) and CXCL10 (1,200 ng/mouse) upon adoptive transfer into syngeneic recipients in vivo (B and C). In some
instances, T cells were treated with the GPCR (G1) inhibitor pertussis toxin (PTX, 0.1 ng/ml) for 1 hr at 37C prior to use.
(legend continued on next page)
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in turn, could enhance adhesion and migration via GPCR
stimulation.
Similarly, a number of other chemokines that have been impli-
cated in heart transplant rejection (Schnickel et al., 2008; Hu¨ser
et al., 2005) were detected in Thgf cells including other CCR5
ligands (CCL3, CCL5) and the CCR4 ligands CCL22 and
CCL17, which are increased by c-Met signals (except CCL17)
(Figure S3).
The molecular mechanisms of c-Met-induced CXCR3 and
CCR4 expression and responsiveness were further investigated
by a series of in vitro experiments, which revealed that STAT-3
activation by c-Met is instrumental for the increased expression
and responsiveness of these chemokine receptors by Thgf cells
(Figure S4).
HGF Is Produced in the Cardiac Parenchyma and
Instructs T Cell Cardiotropism
In addition to its canonical source, the liver, HGF has been pre-
viously invoked to be present in heart tissue where it is required
for the mobilization of cardiac stem cells (Leri et al., 2005). In
animal models, HGF is transiently produced in the heart upon
myocardial ischemic injury (Ono et al., 1997), which in humans
can be followed by autoimmune responses against cardiac
tissue.
To identify physiologic sites of T cell priming in the presence of
HGF, we analyzed and compared the production of HGF mRNA
by a number of murine tissues, including liver and heart, both in
steady-state conditions and 24 hr after the injection of 100 mg
LPS. As shown in Figures 3A–3C, in addition to the liver, heart
parenchyma was found to express HGF mRNA, particularly in
inflammatory settings provoked by endotoxin. Immunohisto-
chemical analysis confirmed that this cytokine is constitutively
present in low amounts in cardiac tissue, and it is upregulated
by inflammatory stimuli induced by LPS (Figure 3C). In addition,
mRNA transcripts for the chemokine CXCL10, but not CCL4 or
CCR4 ligands, were found induced in inflamed cardiac tissue
(Figure 3D).
Given the ability of HGF to affect the reprogramming of migra-
tory receptors in T cells, we subsequently sought to investigate
its distribution within the cardiac parenchyma and heart-draining
LNs. Analysis of murine cardiac tissue and draining LNs
confirmed the presence of endogenous HGF in both tissues
where it co-localized with CD11c+ and CD31+ cells (Figures
S5A and S5B), suggesting that locally produced HGF is dis-
played by DCs and the vasculature—probably via binding to gly-
cosaminoglycans (GAGS), which are used by both cell types to
immobilize chemokines and growth factors (Bao et al., 2010;
Hartmann et al., 1998; Santiago et al., 2012). Thus, it is likely
that HGF produced in the heart parenchyma reaches the drain-(D) Supernatant was harvested from Thgf cells stimulated for 6 hr with HGF (SNH
5 mm pore transwells. Migration of Tnt cells to the SNs and indicated controls was
Thgf cells stimulated with HGF or unstimulated was measured by ImageStream
(E–G) Representative images and histograms. In (F), a representative image of Th
of CCL4. Scale bar represents 10 mm.
(H) Migration of Tnt cells to SNHGF or SNmed in the presence or absence of a neu
(I) Tnt and Thgf cells were perfused over recombinant VCAM-1-Fc-coated flow ch
was added to the perfusion medium. T cell adhesion was quantified as describe
Data are represented as the mean MFI (A, D, E, H) or mean percentage migration
design ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.ing LNs both by direct transfer (to HEV, possibly via conduits)
and bound to migrating DCs.
Based on the observations above and the finding that HGF im-
prints a unique migratory phenotype in T cells, we next sought to
establish whether this phenotype correlates with a specific traf-
ficking pattern of T cells activated in the presence of HGF. First,
in vitro activated Thgf or Tnt cells were labeled and injected intra-
venously into syngeneic recipients and their localization to a
variety of tissues was assessed by wide-field fluorescence
microscopy. As shown in Figure 3E, unlike control Tnt cells,
Thgf cells preferentially localized to the heart and the liver
compared to other organs, suggesting that HGF contributes to
imprinting these homing patterns in T cells. In addition, pre-treat-
ment of Thgf cells with the c-Met inhibitor prevented their local-
ization to the heart, indicating that HGF not only instructs, but
also mediates, T cell cardiotropism. In contrast, c-Met inhibition
did not affect Thgf cell localization to the liver, suggesting that
additional molecular interactions support T cell migration to
this organ (Lalor et al., 2002; Shetty et al., 2011). Similar results
were obtained upon selective inhibition of c-Met in T cells with
lentiviral-delivered, specific shRNAs (Figures S1D and S1E).
Further experiments confirmed that in vivo priming of T cells in
the presence of HGF, although not affecting their proliferation
and cytokine production (Figures S5C–S5H), induced upregula-
tion of c-Met, CCR4, and CXCR3 expression and function
(Figures S5I–S5O), leading to the acquisition of cardiotropism
(Figures S6A and S6B).
c-Met, CXCR3, and CCR4 Differentially Contribute to
T Cell Migration to the Heart
Both CXCR3 and CCR4 have been shown to promote the devel-
opment of T cell infiltration of cardiac tissue in heart allograft
rejection (Hancock et al., 2001; Hu¨ser et al., 2005). To establish
the relative role of c-Met, CXCR3, and CCR4 in mediating T cell
homing to the heart, we performed a series of experiment in
which WT Thgf cells were co-injected with differentially labeled
Thgf cells generated from CCR4- or CXCR3-deficient mice in
saline- or LPS-treated mice. Some CCR4KO or CXCR3KO
T cells were also treated with a blocking anti-CXCR3 antibody
or CCR4 inhibitor, respectively, prior to adoptive transfer. As
shown in Figures 4A and 4C, Thgf cell migration to the heart of
saline-treated mice was not affected by lack of either CCR4 or
CXCR3. In contrast, migration of CCR4- or CXCR3-deficient
Thgf cell to the heart of LPS-treated mice was similarly impaired
compared to that of WT Thgf cells (Figures 4B and 4D).
Additional blockade of either receptor did not further inhibit
T cell localization. Co-injected T cells were retrieved in similar
numbers in the spleen of recipients, independently of the exper-
imental conditions. These data indicate that both CXCR3- andGF) or left in serum-free medium (SNmed) and placed in the bottom chamber of
measured over the next 6 hr. In parallel, expression of the chemokine CCL4 by
analysis.
gf cells stimulated with HGF highlighting the intracellular compartmentalization
tralizing anti-CCL4 antibody.
ambers. Where indicated, a neutralizing anti-CCL4 antibody or isotype control
d in Supplemental Experimental Procedures.
(B, F) or adhesion (I) measured in three independent experiments of identical
Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1091
Figure 3. HGF Is Produced in the Heart and Induces T Cell Cardiotropism
(A) Relative HGF mRNA after intraperitoneal injection of saline solution (steady-state) or LPS (100 mg/mouse) as assessed by qPCR in the indicated tissues and
normalized to a housekeeper gene (Gapdh).
(B) Comparison of mRNA expression in the heart, liver, and skin tissues from untreated and LPS-treated mice. Data show the mean of three independent
experiments (±SEM).
(C) 5 mm-thick frozen sections of either steady-state (SS) or inflamed tissue (LPS) were incubated overnight with an anti-HGF antibody at 15 mg/ml in 4C.
Subsequently, a biotinylated secondary antibody was applied, and HSS-HRP/DAB system used for color development. Sections were counterstained with
hematoxylin to visualize nuclei (magnification 103, scale bars represent 100 mm).
(D) Relative mRNA expression of the indicated chemokines and after intraperitoneal injection of saline (steady-state) or LPS. Data show the mean of three in-
dependent experiments (±SEM).
(E) In vitro activated Thgf and Tnt cells were labeled with PKH26 (5 mM) (red) and CFSE (4 mM) (green), respectively, and co-injected (107/mouse) i.v. into syngeneic
C57BL/6 recipients. Some Thgf and Tnt cells were pre-treated with the c-Met inhibitor (INH) PHA-665752 overnight at 0.3 ng/ml/106 cells, in 37C.
Localization of labeled T cells in the various tissues was analyzed 24 hr later by wide-field fluorescence microscopy. Representative images are shown (upper
images show co-injected Thgf and Tnt cells and lower images show co-injected Thgf and inhibitor-treated Thgf cells). The mean number of cells detected in ten
randomly selected fields (103-magnified) from at least three sections of tissue samples from each recipient (±SD) is shown below each set of images. Scale bars
represent 50 mm. **p < 0.01, ***p < 0.005.CCR4-mediated signals are required for T cell infiltration of the
heart in inflammatory but not steady-state conditions. Experi-
ments conducted with WT Thgf cells treated with either the
CCR4 inhibitor or the CXCR3 blocking antibody prior to adoptive
transfer confirmed that both receptors are required for entry of
the T cells in the heart of LPS-treated animals (Figures S6C–
S6F). In vitro, inhibition of either or both CXCR3 and CCR4 eli-
cited a similar reduction in Thgf cell migration to a combination
of CXCL10 and CCL22, further suggesting a crosstalk between
the two receptors (Figure S6G).
As expected, PTX pre-treatment inhibited Thgf cell migration
to the heart of non-inflamed mice (Figure 4E) consistent with1092 Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authorsour observation that c-Met signals support their recirculation to
cardiac tissue via its effects on GPCRs. Untreated recipients
were used in these experiments tominimize Thgf cell recruitment
via CCL22 and CXCL10 as observed in LPS-treated recipient
mice.
Given our previous observation that Thgf cells produce a
number of CCR5 ligands, we sought to confirm the role of these
chemokines in mediating T cell cardiotropism by generating
CCR5-deficient Thgf cells and monitoring their recruitment to
the heart both in non-inflamed and LPS-treated mice. As
shown in Figures 4F and 4G, lack of CCR5 expression inhibited
Thgf cell migration to the heart both in steady-state and
Figure 4. c-Met, CXCR3, or CCR4 Differentially Contribute to T Cell Cardiotopism in Steady-State Conditions and during Inflammation
(A–D) In vitro activated Thgf cells fromWT andCCR4 (A and B) or CXCR3 (C andD)mice were differentially labeled and co-injected (107/mouse) i.v. into syngeneic
C57BL/6 recipients that had received either saline solution or LPS (as indicated in the panels) i.p. 48 hr earlier. Some CCR4- or CXCR3-deficient Thgf cells were
treated with an anti-CXCR3 antibody or a CCR4 inhibitor (B and D), respectively, prior to co-injection with untreated cells in LPS-treated recipients.
(E) WT Thgf cells were also treated with PTX (0.1 ng/ml) for 1 hr at 37C, washed in PBS, labeled with CFSE, and co-injected with untreated PKH26-labeled Thgf
cells.
(F and G) Thgf cells from WT and CCR5 mice were co-injected (107/mouse) i.v. into syngeneic C57BL/6 recipients that had received either saline solution (F) or
LPS (G) i.p. 48 hr earlier. Some CCR5-deficient Thgf cells were treated with an anti-CXCR3 antibody or a CCR4 inhibitor (G) prior to co-injection with untreated
cells in LPS-treated recipients.
Localization of labeled T cells in the heart was analyzed 24 hr later by wide-field fluorescence microscopy. T cell localization in the spleen was also assessed to
ensure that similar cell numbers had been injected. Representative images are shown in the right side of each panel, with label coding indicated on top. Themean
number of cells detected in ten randomly selected fields (103-magnified) from at least three sections of tissue samples from each recipient (±SD) is shown in the
left side of each panel. n = 3, N = 2. Scale bars represent 100 mm. **p < 0.01, ***p < 0.005, ****p < 0.001.inflammatory conditions. However, CCR5-deficient Thgf cells
access to heart tissue of LPS-treated mice was further
inhibited by CCR4 or CXCR3 blockade, suggesting that
c-Met-mediated production and release of CCR5 ligands pro-
vide additional stimuli for the recruitment of cardiotropic
T cells during inflammation.
c-Met+CCR4+Memory T Cells Preferentially Recirculate
to the Heart
Having established that HGF-induced cardiotropism is associ-
ated with the expression of c-Met and CCR4 by memory
T cells, we sought to investigate the physiological relevance of
this molecular area code by assessing the phenotype of T cells
retrieved from cardiac tissue in steady-state conditions and dur-ing heart-specific immune responses. To this aim, T cells were
retrieved from B6Kd-derived heart allograft and the native heart
of C57BL/6 recipients and analyzed for the expression of c-Met
and CCR4. This strain combination gives rise to CD8+ T cell-
mediated direct alloresponses against intact Kd molecules and
CD4+ T-cell-mediated indirect alloresponses against a single
Kd-derived peptide in the context of H2b molecules (Honjo
et al., 2004). As a control, CD44hi T cells retrieved from the spleen
were also examined. As shown in Figure 5, T cells from native
and transplanted heart expressed high amounts of c-Met (Fig-
ures 5A and 5B) and CCR4 (Figures 5C and 5D) compared to
memory T cells in the spleen. In addition, a high proportion of
heart-resident T cells co-expressed both receptors, including
in the lymph nodes draining native hearts (Figures 5E and 5F).Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1093
Figure 5. T Cells that Localize to Cardiac Tissue Express c-Met and CCR4
(A–D) T cells were obtained by enzymatic digestion of B6Kd heart allograft 2 weeks after transplantation into C57BL/6 mice (HeartTX), and from C57BL/6 native
hearts (HeartN). As a control, splenic T cells from naive C57BL/6micewere used.Memory T cells were identified by gating on the CD44
hi T lymphocyte population.
Expression of the HGF receptor c-Met by CD44hi CD4+ and CD8+ T lymphocytes from all populations is shown in (A) (representative histograms). Expression of
CCR4 by the same T cell populations is shown in (C). The mean MFI of c-Met and CCR4 from three samples are shown in (B) and (D), respectively.
(E) Dot plots depict co-expression of c-Met and CCR4 by T cells populations isolated from B6Kd heart allograft 2 weeks after transplantation into C57BL/6 mice
(HeartTX) and from native recipients’ hearts (HeartN) and their draining lymph nodes (dLN HeartN), and from control spleens.
(F) Mean percentage of double-positive CD44hi CD4+ and CD8+ T cells (±SD, n = 3, N = 2).
*p < 0.05, **p < 0.01.CXCR3 expression was similar in all the T cell populations
analyzed (not shown), possibly due to the relatively late time
point of T cell harvesting.1094 Immunity 42, 1087–1099, June 16, 2015 ª2015 The AuthorsThese observations indicate that c-Met- and CCR4-express-
ing T cells are enriched in heart tissue both in steady-state and
inflammatory conditions, suggesting that expression of these
receptors is instrumental for physiological T cell recirculation to
the heart and associated lymphoid tissue.
c-Met Blockade Prevents Rejection of Heart Allografts
by Promoting Selective Topographic Ignorance
To establish the selectivity of T cell homing imprinting by HGF,
we then compared the effect of pharmacological blockade of
c-Met on the survival of B6Kd-derived heart or skin grafts trans-
planted in C57BL/6 recipients. All recipients received a depleting
anti-CD8 antibody prior to transplantation (125 mg/mouse i.p. on
day –1) (Tsang et al., 2008) to remove potential pre-existing
cross-reactive memory alloresponses and ensure that the
ensuing response against Kd alloantigens is derived from naive
T cells (i.e., still susceptible to HGF effects). CD8+ T cell numbers
recovered by 72 hr after depletion, as previously described
(Tsang et al., 2008). Some recipients were treated daily with
the c-Met inhibitor PHA-665752 i.p. (500 mg/mouse) for 2 weeks
after transplantation. This schedule was designed in order to
target the priming phase of immunity, when the acquisition of
homing properties is known to occur, and to avoid affecting
the beneficial effects of HGF on heart tissue, including tissue
repair and vascularization (Madonna et al., 2012). Control groups
received saline solution with vehicle alone.
As shown in Figures 6A and 6B, pharmacological c-Met
blockade led to long-term heart allograft survival in 75% of the
recipients compared to controls. In contrast, skin allograft sur-
vival was not affected, indicating that c-Met inhibition selectively
targets T cell responses against heart tissue irrespective of anti-
gen specificity.
Histological analysis of HE-stained grafts and native heart re-
vealed severe inflammatory lesions in the grafts of recipients
treated with vehicle alone, which were attenuated in PHA-
665752-treated recipients (Figures 6C and 6D).
Co-staining of elastine and smooth muscle cells (SMCs) alpha
actin revealed signs of vasculopathy (narrowing of the lumen and
perivascular proliferation of SMCs) in vehicle-treated recipients,
which were abrogated by the administration of the c-Met inhibi-
tor (Figures 6C and 6E). Syngeneic graft and native hearts were
free of disease.
Graft infiltration by CD4+ and CD8+ T cells was assessed by
immunostaining with anti-CD4 or anti-CD8 primary antibodies
followed by AlexaFluor488-conjugated secondary antibody. As
shown in Figures 6F and 6G, T cell infiltration of the hearts of
PHA-665752-treated mice was reduced compared with that
observed in vehicle-treated recipients, particularly in the CD8+
T cell subset, which is in fact responsible for direct allorecogni-
tion of Kd MHC class I molecules in this combination (Honjo
et al., 2004).
T cells separately isolated from heart graft draining or non-
draining lymph nodes and the spleen of heart allograft recipients
at the time of rejection or 100 days after transplantation dis-
played strong proliferative responses to B6Kd splenocytes
(direct alloresponses; Figure 6H) and to the Kd peptide presented
by syngeneic splenocytes ex vivo (indirect alloresponses; Fig-
ure 6I) irrespective of the treatment with the c-Met inhibitor and
the occurrence of rejection, suggesting that c-Met blockade
does not affect T cell priming nor leads to the induction of toler-
ance. Rather, as confirmed by substantial inhibition of T cell infil-
tration of heart grafts from inhibitor-treated recipients, c-Metblockade impaired the ability of primed T cells to localize to the
heart.
Liver-derived human T cells have been shown to migrate in
response to HGF in vitro (Adams et al., 1994). We therefore
sought to investigate whether the HGF-mediated induction of
cardiotropism in T cells is operational in humans. To this aim,
we developed a model of human heart xenograft transplanted
subcutaneously in SCID/Beige mice. This model has been previ-
ously used to identify molecular patterns of migration to human
synovial tissue, lymph nodes, and skin (Garrood et al., 2009).
Within 2–3 weeks, human heart xenografts become vascularized
by mouse vessels, which formed direct anastomosis with the
intact human vasculature (Figures S7A–S7C). Human naive
T cells (CD45RO), isolated by immunomagnetic negative selec-
tion, were activated with plastic-bound anti-CD3 and anti-CD28
antibodies in the presence or absence of HGF. Because
commercially available anti-human c-Met antibodies are not
suitable for flow cytometric analysis (Adams et al., 1994), binding
of HGF to human naive, Thgf, and Tnt cells was assessed by in-
cubation with DyLight-488-labeled HGF, which revealed low
binding of HGF on naive T cells, which selectively increased in
Thgf cells, where it appeared to co-localize on the cell surface
with the integrin LFA-1 (Figures S7D–S7F). Thgf and Tnt cells
were then labeled with distinct fluorochromes and injected i.v.
into SCID/Beige recipients of a double xenograft of human heart
and skin tissue transplanted 4 weeks earlier. Grafts and spleen
were retrieved 48 hr later and cell localization analyzed by
wide-field fluorescence microscopy. As shown in Figures 7A–
7F, Thgf but not Tnt cells were enriched in heart but not skin
xenografts. Thgf cell migration to heart tissue was inhibited by
pretreatment with the c-Met inhibitor. Although not significant,
increased numbers of Thgf cells were retrieved in the recipients’
spleen, but the c-Met inhibitor did not alter this effect (Figures
7G–7I). Overall, these findings suggest that the induction of
T cell cardiotropism via the HGF-c-Met axis is also operational
in the human system.
DISCUSSION
The present study describes a novel molecular signature of T cell
cardiotropism, which is imprinted in T cells primed in the
presence of the cytokine HGF and is characterized by c-Met
expression and enhanced CCL22- and CXCL10-induced che-
mokinesis. In addition to imprinting T cells with cardiotropism,
HGF also indirectly promotes migration of T cells to the heart.
Based on our observations, HGF produced by the myocar-
dium is transported to the heart-draining LN either passively or
bound to DCs. HGF has high affinity for heparan sulfate proteo-
glycans that sequester the ligand and probably localize the
action of HGF-SF only to the surrounding c-Met-expressing
cells. We noticed that ectopically administered HGF localizes
only on CD11c-expressing cells in skin-draining LNs, suggesting
a specialization of HEV in heart-associated lymphoid tissue.
Thus, DC-bound HGF is probably responsible for the imprinting
of cardiotropism during T cell priming, whereas HGF associated
to the vasculature probably contributes to cardiotropic memory
T cell recruitment during inflammation.
T cell recruitment to the heart by locally produced HGF
appears to be a dominant mechanism during constitutive T cellImmunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1095
Figure 6. Inhibition of the HGF-c-Met Axis
Prevents T-Cell-Mediated Heart but Not
Skin Allograft Rejection
(A and B) C57BL/6 mice received either a B6Kd
heart or skin graft 24 hr after i.v. administration of
a depleting anti-CD8 antibody (125 mg/mouse).
Some recipients were treated with the c-Met
inhibitor PHA-665752 i.p. (25 mg/kg daily) for
2 weeks after transplantation. Graft survival in
heart (A) and skin (B) is shown. N = 2, n = 4.
(C) Both transplanted and native hearts were har-
vested after rejection or 100 days after trans-
plantation. At least five sections from each heart
was processed and stained with hematoxilin/
eosin. Left: representative tissue images were
scanned with an Olympus in a brightfield mode.
Right: Tissue sections underwent immunoperox-
idase staining for smooth muscle cells using rabbit
monoclonal antibody to mouse alpha-actin, fol-
lowed by Miller’s elastin stain, and counterstained
with hematoxylin. Luminal occlusion was evalu-
ated by tracing the cross-section of each vessel’s
internal elastic lamina and lumen using software in
two transverse sections per graft. Each panel
shows a representative tissue image. Magnifica-
tion: 103.
(D) Each sample was subjected to single blinded
pathologic assessment, as described in Experi-
mental Procedures. The mean histopathological
scores ± SD of transplanted hearts stained with HE
were observed in at least three samples obtained
from each recipient (at least three animals/group).
(E) The mean percentage luminal occlusion ± SD
was observed in three samples obtained from each
recipient (at least three animals/group).
(F and G) Tissue sections were stained with pri-
mary purified anti-CD4 or anti-CD8 antibodies and
secondary AlexaFluor488 antibody. Shown are the
mean CD4+ (F) and CD8+ (G) T cell infiltration
observed in three samples obtained from each
recipient (at least three animals/group).
(H and I) T cells from draining and non-draining
lymph nodes and the spleen of recipient animal
were harvested at the time of rejection or 100 days
after transplantation. T cells were incubated with
B6Kd splenocytes for 48 hr, followed by pulsing
with [3H] thymidine to assess T cell proliferation.
Shown are representative proliferation assays
(mean of triplicate cultures ± SD) of T cells from
C57BL/6 recipients of B6Kd hearts treatedwith the
c-Met inhibitor or vehicle alone (H) or recipient of
syngeneic hearts to B6Kd splenocytes or to
C57BL/6 splenocytes loaded with the Kd peptide
epitope (I) (±SD).
*p < 0.05, **p < 0.005, ***p < 0.001.recirculation and immunosurveillance, as suggested by the
observation that c-Met inhibition abrogated T cell localization
to cardiac tissue in steady-state conditions. HGF-mediated
recruitment occurred indirectly via the induction of chemokine
secretion by c-Met-expressing T cells. A similar mechanism
has been described in T cell migration induced by IL-6
(McLoughlin et al., 2005). It is possible that this mechanism
also applies to a number of cytokines and growth factors,1096 Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authorswhich have been reported to elicit chemotactic responses by
T cells.
During inflammation, the chemokine receptors CCR4 and
CXCR3 enhanced T cell recruitment to the heart, as has been
previously shown in heart transplantation settings (Hancock
et al., 2001; Hu¨ser et al., 2005).
Co-expression of the CCR4 and CXCR3 chemokine receptors
and high responsiveness to their cognate ligands, which are
Figure 7. The HGF-c-Met Axis of T Cell Homing to the Heart Is Oper-
ational in the Human System
Human heart and skin tissue (xenografts, XG) were transplanted into Beige
SCID C.B-17 mice. Purified human naive T cells previously activated by
plastic-bound anti-CD3 and anti-CD28 antibodies in the presence of HGF
(Thgf) or in medium alone (Tnt) for 7 days were injected i.v. on day 28 after
grafting. Grafts were removed 48 hr later, embedded in OCT, and snap frozen.
The presence of Thgf cells labeled with PKH-26 (red) or Tnt labeled with CFSE
(green) in the heart (A) and skin (D) grafts and the recipient’s spleen (G) was
assessed bywide-field fluorescencemicroscopy. In parallel experiments, Thgf
and Tnt cells were treated with the c-Met inhibitor (INH) and differentially
labeled prior to co-injections in xenograft recipients (combinations: Thgf plus
Thgf [INH] and Tnt plus Tnt [INH]). Representative tissue images of heart (B)
and skin (E) xenografts and the recipient’s spleen (H) are shown. The mean
(±SD) number of labeled T cells counted in at least three 103 fields from
sections isolated from eight grafts and the recipient’s spleens are shown in (C),
(F), and (I) (N = 2, n = 4). ***p < 0.0005, scale bars represent 100 mm.generally thought to be largely restricted to the T helper type 1
and 2 cell subsets, respectively, in humans (Kitamura et al.,
1998), is a key feature of cardiotropic T cells. Engagement of
both receptors was required for T cell access to the heart in in-
flammatory conditions, in line with previous reports. The contri-
bution of CCR4 and CXCR3 to cardiotropic T cell recruitment
appeared to be cooperative rather than additive: lack or inhibi-
tion of each or both receptors similarly reduced T cell access
to the heart parenchyma. It is possible that these two receptors
cross-regulate each other, as has been described in manyGPCRs (Vischer et al., 2011), including the CXCR3-CCR4 pair
in which CXCR3 has been shown to enhance CCR4 responsive-
ness (Sebastiani et al., 2005). In contrast, CCR5 signals only
partially inhibited T cell localization to the heart during inflamma-
tion, which is further reduced by inhibition of CCR4 or CXCR3 in
an additive manner. In line with this observation, CCR4 signaling
is enhanced by the CXCR3 but not by the CCR5 ligands CCL3
and CCL4 (Sebastiani et al., 2005).
It is interesting to note that in our model, CCR4 and CXCR3
ligands were produced either by the heart (CXCL10) or by Thgf
cells (CCL22/CCL17), and that CCL22 was released by T cells
after c-Met triggering. These observations raise the alternative
or additional possibility that CCR4 might be crucial for T cell
recruitment by contributing to HGF ‘‘presentation’’ and c-Met
triggering by the heart endothelium, while CXCR3 might be
important for the retention of recruited T cells in the cardiac
parenchyma.
Exposure to HGF during priming also promoted the imprinting
of T cell hepatotropism. However, differently from what we
observed for cardiotropic T cells, HGF-mediated hepatotropic
T cell migration to the liver was only partly reduced by c-Met in-
hibition. These observations indicate that, although HGF is suffi-
cient for the induction of hepatotropism, molecular interactions
other than those mediated by c-Met can mediate T cell recircu-
lation in the liver (Lalor et al., 2002; Shetty et al., 2011).
Our findings are in line with the recent observation that soluble
factors produced in selected tissues and drained in the local
lymphatic stations contribute to the topographic imprinting of
T cells during activation (McCully et al., 2012). These observa-
tions suggest that specialized, tissue-derived DCs are dispens-
able in some mechanisms of homing imprinting. Further, the
effectiveness of c-Met inhibition in preventing the induction of
T cell cardiotropism in a heterotopic heart allograft suggest
that the tissue itself dictates the environmental cues that affect
T cell differentiation in draining lymph nodes.
The possibility that tissue-specific soluble factors can induce a
defined and unique topographic molecular signature paves the
way for new investigations aimed to a more comprehensive
mapping of organ-selective T cell immunity with a substantial
clinical impact. In our study, transient inhibition of HGF-c-Met
axis during T cell priming selectively disrupts T cell homing and
immune inflammation in the heart without affecting T cell re-
sponses in the skin. These findings have immediate implications
for the development of novel therapies aimed at selectively tar-
geting heart immunity while preserving immune protection in
other sites (organ-selective immunosuppression).
The temporary blockade of c-Met required to achieve this
effect should not impact on thewell-established long-term bene-
ficial effects of HGF on heart tissue (Hu¨ser et al., 2005), as it is
also indicated by the minimal pathological signs in the grafts
from treated animals.
Notably, disruption of the HGF-c-Met axis did not induce T cell
tolerance, as indicated by the presence of primed alloresponses
in non-rejectors. Rather, we argue that temporary c-Met inhibi-
tion prevented the development of topographic memory of the
heart by T cells resulting in their failure to access the heart allo-
graft. Further studies will be required to fully develop the clinical
potential of this strategy, including determining the duration and
plasticity of HGF-induced cardiotropism in primed T cells.Immunity 42, 1087–1099, June 16, 2015 ª2015 The Authors 1097
EXPERIMENTAL PROCEDURES
Heart Transplantation
Heterotopic heart transplantation was performed by placing the donor heart
into the recipient’s (WT and B6Kd) sternomastoid cavity, connecting the aortal
branch to the carotid artery and the pulmonary vein to the jugular vein. All
grafts and native hearts were evaluated by histopathologic criteria in a
single-blinded manner and scored to grade the degree of inflammation from
0 to 4 (0, no inflammation; 1, light focal lymphohistocytic infiltrate; 2, moderate
focal lymphohistocytic infiltrate with myocardial involvement; 3, moderate to
severe inflammation with focal vasculopathy and myocyte degeneration; 4,
severe inflammation, vasculopathy, and myocardial fiber loss). Slides were
scanned with an Olympus VS-120 using brightfield mode. Images were
analyzed with VS-ASW software.
Luminal occlusion was evaluated by tracing the cross-section of each
vessel’s internal elastic lamina and lumen using Lucia NIS elements software
(Nikon UK) in three transverse sections per graft. All vessels in each section,
which demonstrated clear staining of elastin laminar and presence of smooth
muscle cell (SMC) alpha-actin, were measured in three sections of each
heart.
Isolation of T Cells from Heart Tissue
To isolate T cells from heart tissue, native or transplanted murine hearts were
harvested and cut into small pieces. The tissue fragments were digested in
1 ml Hanks medium, containing 608 U/ml Collagenase I (Sigma), 187.5 U/ml
Collagenase XI (Sigma), 90 U/ml Hyaluronidase (Sigma), and 90 U/ml DNase
(Sigma), for 1 hr at 37Cwith agitation. Digested samples were passed through
a 70 mm cell strainer to obtain a single-cell suspension and were then washed
in FACS buffer before cell surface staining with a 1:200 dilution of conjugated
antibodies against CCR4-PE (Biolegend), CXCR3-PerCP (Biolegend), CD4-
PECy7 (Biolegend), CD8-APC (Biolegend), and CD44-af450 (eBioscience).
Cells were incubated for 1 hr at 4C before being washed twice in FACS buffer
and then fixed with 200 ml Fixation Buffer (eBioscience) for 1 hr at 4C. Cells
were washed twice with Fixation/Permeabilisation buffer before intracellular
staining with a 1:200 dilution of FITC-conjugated antibody against c-Met
(eBioscience). Cells were incubated for 1 hr at 4C before being washed
twice in Fixation/Permeabilisation buffer and being analyzed on a FACS
Fortessa (BD).
HGF Binding to Human T Cells
Permeabilized (cell permeabilization kit, eBioscience) T cells were incubated
with Dylight 488-labeled (500 ng/ml, ThermoScientific) human recombinant
HGF (Peprotech) and rat-anti mouse CD4 and LFA-1 antibodies for 40min, fol-
lowed by washing in PBS. Cells were resuspended in fix buffer and analyzed
using ImageStream technology (MK II, Amnis). Data were analyzed with IDEAS
6.0 software (Amnis). For analyses, total cells were gated on in focus and single
cells. Single cells were then analyzed for HGF intensity within the total
CD4+LFA-1+ population (mean intensity values shown).
Human Tissue Transplantation into SCID Mice
Small human heart tissue samples were collected from the right atrium and
non-ischemic part of the left ventricle in patients undergoing routine coronary
bypass surgery and skin tissue was obtained from patients undergoing
cosmetic surgery, according to a protocol approved by the local ethical com-
mittee and after written informed consent by the patient.
Human heart and skin tissue samples (4 3 4 mm) were transplanted
into Beige SCID C.B-17 mice. Two small incisions were made in the skin
behind each ear of one mouse and the heart biopsies were carefully inserted
subcutaneously in a dorsal position distal to the shoulder joints (two trans-
plants per animal). The incisions were closed with a soluble suture. Mice
were monitored for 4 weeks before grafts were exteriorized and removed
for analysis.
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